Literature DB >> 596520

Immunoglobulin and complement receptors on human eosinophils and their role in cellular adherence to schistosomules.

E A Ottesen, A M Stanley, J A Gelfand, J E Gadek, M M Frank, T E Nash, A W Cheever.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 596520     DOI： 10.4269/ajtmh.1977.26.134

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  7 in total

1.  Comparison of human eosinophils from normals and patients with eosinophilia.

Authors:  D A Bass; W H Grover; J C Lewis; P Szejda; L R DeChatelet; C E McCall
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

2.  Diethylcarbamazine citrate, an antifilarial drug, stimulates human granulocyte adherence.

Authors:  C H King; B M Greene; P J Spagnuolo
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

3.  Evaluation of spleen lymphocyte responsiveness to a T-cell mitogen during early infection with larval Taenia taeniaeformis.

Authors:  T Letonja; C Hammerberg; G Schurig
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

4.  Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils.

Authors:  G M Walsh; A B Kay
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

5.  Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA).

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

6.  Comparison of the role of complement in immunity to Schistosoma mansoni in rats and mice.

Authors:  D A Vignali; Q D Bickle; M G Taylor; G Tennent; M B Pepys
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

7.  Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence.

Authors:  A E Butterworth; M A Vadas; D L Wassom; A Dessein; M Hogan; B Sherry; G J Gleich; J R David
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.